Apollo Funds Complete €3 Billion Capital Solution for Bayer

{
  "signal_id": "b30e28c6-d9d6-f45d-7d39-ec98fa873090",
  "signal_type": "news",
  "signal_subtype": "invests_into",
  "detected_at": "2026-09-16T07:00:00+00:00",
  "company": {
    "name": "KKR",
    "domain": "kkr.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/09/16/3362850/0/en/apollo-funds-complete-3-billion-capital-solution-for-bayer.html",
    "title": "Apollo Funds Complete €3 Billion Capital Solution for Bayer",
    "excerpt": "NEW YORK and LEVERKUSEN, Germany, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates (“Apollo”) have successfully closed a €3 billion capital solution for Bayer, previously announced on July 10. KKR has joined Apollo as a significant minority participant in the investment. Under the transaction, Apollo, together with KKR, have invested equity capital into a newly established entity holding Bayer's long-acting reversible contraceptives (LARC) business. Bayer retains a majority stake in the entity and continues to exercise full operational control over the business; there are no changes to the LARC strategy as a result of the investment. Apollo Partner Jamshid Ehsani said, “We are proud to serve as a capital partner to Bayer, originating and leading a multi-billion-euro capital solution tailored to their needs. Bayer, a global life sciences leader and iconic German company, represents the types of large, blue-chip companies we serve through our High Grade Capital Solutions business.” Ehsani added, “Apollo has committed to deploying more than $100 billion in Germany over the coming decade, and Bayer exemplifies the kind of strategic, long-term partnership we seek to build with the country's most important companies.” Centerview Partners served as financial advisor to the Apollo Funds. Latham & Watkins LLP, Paul, Weiss...",
    "summary": "KKR has joined Apollo as a significant minority participant in a €3 billion capital solution for Bayer's long-acting reversible contraceptives (LARC) business.",
    "location": "Leverkusen, Germany",
    "planning": false,
    "image_url": "https://ml.globenewswire.com/Resource/Download/24205df4-cb1e-4a5f-89c1-5ebcc2e59b81",
    "confidence": 0.9,
    "published_at": "2026-09-16T07:00:00Z",
    "location_data": [
      {
        "city": "Leverkusen",
        "state": "North Rhine-Westphalia",
        "region": "Western Europe",
        "country": "Germany",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-09-16",
    "article_sentence": "KKR has joined Apollo as a significant minority participant in the investment.",
    "financing_type_tags": [
      "equity"
    ],
    "related_company_name": "Bayer",
    "related_company_domain": "bayer.com"
  }
}

curl https://signals.autobound.ai/v1/signals/b30e28c6-d9d6-f45d-7d39-ec98fa873090 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"kkr.com","limit":20}'